ArticleInternational ophthalmology2026

Faricimab for treatment-naïve nAMD: 1- and 2-year outcomes and PS-OCT polarimetric entropy.

Teruki Katabami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.